Brief: CVS Group Says Engaging With CMA On Proposed Remedies Related To Veterinary Market Investigation
Nov 18 (Reuters) - CVS Group PLC CVSG.L: CVS GROUP PLC - SALES UP 5.7%, ADJUSTED EBITDA UP 6.2% IN FOUR-MONTH PERIOD TO 31 OCTOBER (ADDS DROPPED WORD 'ADJUSTED') CVS GROUP PLC: IS ENGAGING WITH CMA ON PROPOSED REMEDIES RELATED TO VETERINARY MARKET INVESTIGATION CVS GROUP PLC: REMAINS CONFIDENT IN GROUP'S ABILITY TO DELIVER FULL YEAR 2026 RESULTS IN LINE WITH MARKET EXPECTATIONS Further company coverage: CVSG.L ((Reuters.Briefs@thomsonreuters.com;))